Quidel Pharmaceuticals Private Limited
About Quidel Pharmaceuticals Private Limited
Data last updated:
Quidel Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 13 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2015PTC206333. Its GSTIN is 10AAACQ3819Q1ZB (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sima Devi and Kumari Bharti Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3rd Flr Fl – 302 99 Lakshminarayantala Road, Kolkata, West Bengal, India – 711103.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.31 Lakh, a decline of 20% compared to the previous year. For the same year it recorded a net loss of ₹1.47 Lakh (net margin -14.3%) and EBITDA of -₹1.45 Lakh (EBITDA margin -14%). Revenue has declined at a compounded annual rate (CAGR) of 52% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Quidel Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address3rd Flr Fl – 302 99 Lakshminarayantala Road, Kolkata, West Bengal, India – 711103
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Quidel Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Quidel Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Quidel Pharmaceuticals Private Limited, buy the company report.
Financials of Quidel Pharmaceuticals Private Limited
FY 2025 filings availableQuidel Pharmaceuticals Private Limited reported revenue of ₹10.31 Lakh (down 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 20% fall in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.45 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -14% | ||||
| Net Profit Margin | -14.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Quidel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Quidel Pharmaceuticals Private Limited
Quidel Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sima Devi | Director | 16 Mar 2020 | 6 Years 7 Months | Current |
| Kumari Bharti Mishra | Director | 13 May 2015 | 11 Years 6 Months | Current |
Auditor
Quidel Pharmaceuticals Private Limited is audited by PRATIK SINGH & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRATIK SINGH & ASSOCIATES | FY 2017 | 019100C |
Shareholding
The shareholding of Quidel Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Quidel Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Quidel Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Quidel Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Quidel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAACQ3819Q1ZB | Bihar | Active | 11 May 2018 |
To see the full GST registrations and return filing status of Quidel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Quidel Pharmaceuticals Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Rohini Kumari ceased to be Director on 10 Sep 2021.
Frequently asked questions
Quidel Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in retailers, within the trading industry. It was incorporated on 13 May 2015 (11+ years old) and is registered under CIN U24100WB2015PTC206333.
Quidel Pharmaceuticals has 2 current directors:
- Sima Devi - Director
- Kumari Bharti Mishra - Director
The latest financial statements of Quidel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Quidel Pharmaceuticals is 10AAACQ3819Q1ZB, registered in Bihar.
The CIN (Corporate Identification Number) of Quidel Pharmaceuticals is U24100WB2015PTC206333. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Quidel Pharmaceuticals was incorporated on 13 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kolkata.
Rohini Kumari ceased to be Director on 10 Sep 2021. Sushant Kumar Mishra ceased to be Director on 10 Sep 2021. Munna Mishra ceased to be Director on 17 Mar 2020. Quidel Pharmaceuticals has 5 board changes on record in total.
The registered office of Quidel Pharmaceuticals is at 3rd Flr Fl – 302 99 Lakshminarayantala Road, Kolkata, West Bengal, India – 711103.
Quidel Pharmaceuticals operates in the trading industry, in the retailers segment.
The compliance status of Quidel Pharmaceuticals is compliant as of 08 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
